PUBLIC NOTICE: RENEWAL OF ANNUAL LICENSES
Date of issue of Public Notice: 1st July, 2019
THE PHARMACY BOARD OF SIERRA LEONE (PBSL) WOULD LIKE TO INFORM THE GENERAL PUBLIC AND ALL PERSONS ENGAGED IN PHARMACY BUSINESS (I.E. PHARMACY STORES, DRUG STORES, PATENT MEDICINE SHOPS) AND ALSO THOSE ENGAGED IN THE SELLING OF COSMETIC PRODUCTS, NUTRITIONAL AGENTS AND ENERGY DRINKS THAT THE DEADLINE DATE FOR THE RENEWAL OF THEIR ANNUAL LICENSES FOR THE YEAR 2019 IS ON THE 31ST JULY, 2019.
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
THE GENERAL PUBLIC IS HEREBY INFORMED THAT CLOSURES OF ALL UNLICENSED PREMISES WILL COMMENCE ON THURSDAY 1ST OF AUGUST, 2019.
YOUR COOPERATION IN THIS ALL IMPORTANT MATTER OF PUBLIC HEALTH AND NATIONAL DEVELOPMENT IS SOLICITED.
JAMES P. KOMEH
Public Notice: Drug Alert
Please be informed that it has been brought to the attention of the Pharmacy Board of Sierra Leone that the under mentioned product is a counterfeit, illegally imported and is not registered by the Pharmacy Board of Sierra Leone contrary to Part VI Section (44) and (55) of the Pharmacy and Drugs Act 2001.
The Pharmacy Board of Sierra Leone therefore cannot guarantee the quality and safety of this product and therefore warns the General Public against its distribution and use.
NOVALGIN I.V. & I.M Manufacturing date: 06/2018
Strength: 500mg/5ml Expiry date: 06/2021
Batch Number: 180616 Manufactured by: Shanghai Medsys Industrial Co.Ltd
All concerned are kindly requested to forward all batches of this product to the Pharmacy Board of Sierra Leone Head Quarter at Central Medical Stores, New England Ville, Freetown or to any of its regional offices in Bo, Kenema, Makeni and Kono for further regulatory action.
James P. Komeh
Public Notice: Drug Alert
Information making rounds on social media about a certain drug called “Menthodex” (pictured below) with an incorrect manufacturing date has been brought to the attention of the pharmacy board. From our investigations, our findings indicate that regulators intercepted the drug in Nigeria and due to our bilateral ties with National Agency for Food and Drug Administration and Control (NAFDAC) Nigeria the Board was notified to be extra vigilant for the product in our market. The board has intensified its post-market surveillance and we will continue to keep the general public updated.
The general public is hereby advised to carefully check the manufacturing details of drugs they purchase and should be rest assured that products registered by Pharmacy Board of Sierra Leone are of good quality, efficacious and safe.
Important announcement concerning a brand of amoxycillin capsules that allegedly caused two deaths, according to an audio clip in circulation. The Board is unaware of and has never registered such a brand of amoxycillin. Read More
Drug Alert: Chloroquine
With immediate effect, Chloroquine phosphate injection manufactured by Syncom Formulations Ltd, India, is to be withdrawn from circulation and quarantined. Read More